Equities

Daito Pharmaceutical Co Ltd

Daito Pharmaceutical Co Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of May 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue46,89545,10143,464
OPERATING EXPENSES
Cost of revenue total37,05634,77032,005
Selling, general and admin. expenses, total3,4313,0823,004
Depreciation/amortization165176152
Unusual expense(income)3126255
Other operating expenses, total--1.001.00
Total operating expense43,03239,92037,166
Operating income3,8635,1816,298
Other, net288.00110
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes4,2185,0766,720
Provision for income taxes1,0401,5492,092
Net income after taxes3,1783,5274,628
Minority interest1167240
Net income before extra. Items3,2943,5994,668
Total extraordinary items------
Net income3,2943,5994,668
Inc.avail. to common excl. extra. Items3,2953,6004,668
Inc.avail. to common incl. extra. Items3,2953,6004,668
EPS RECONCILIATION
Basic/primary weighted average shares161615
Basic/primary eps excl. extra items210228305
Basic/primary eps incl. extra items210228305
Dilution adjustment------
Diluted weighted average shares161615
Diluted eps excl. extra items210227305
Diluted eps incl. extra items210227305
COMMON STOCK DIVIDENDS
DPS - common stock primary issue605545
Gross dividend - common stock935864845
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental41129.00
SUPPLEMENTAL INCOME
Depreciation, supplemental3,6593,8703,313
Total special items3126257
NORMALISED INCOME
Normalized income before taxes4,2495,1026,977
Effect of special items on income taxes7.647.9380
Income tax excluding impact of special items1,0481,5572,172
Normalized income after tax3,2013,5454,805
Normalized income avail. to common3,3183,6184,845
Basic normalized EPS211229316
Diluted normalized EPS211229316
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.